Preclinical Safety Assessment of Bacillus subtilis BS50 for Probiotic and Food Applications

Despite the commercial rise of probiotics containing Bacillaceae spp., it remains important to assess the safety of each strain before clinical testing. Herein, we performed preclinical analyses to address the safety of Bacillus subtilis BS50. Using in silico analyses, we screened the 4.15 Mbp BS50...

Descripción completa

Detalles Bibliográficos
Autores principales: Brutscher, Laura M., Borgmeier, Claudia, Garvey, Sean M., Spears, Jessica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144164/
https://www.ncbi.nlm.nih.gov/pubmed/35630480
http://dx.doi.org/10.3390/microorganisms10051038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144164/
https://www.ncbi.nlm.nih.gov/pubmed/35630480
http://dx.doi.org/10.3390/microorganisms10051038

Ejemplares similares